{
  "trial_id": "NCT01501487",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Women with histologically proven invasive breast cancer and no distant metastases",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Lymphnode negative and a clinical tumor classification of T2 (\u22653.5cm)-T4 or with 1-3 positive lymph nodes and a clinical tumor classification of T2-T4 DCIS or LCIS are allowed in addition to invasive cancer at T2 or T3 level.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age \u2265 18 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "At least one lesion that can be accurately measured in two dimensions utilizing mammogram, ultrasound, or MRI images to define specific size and validate complete pathologic response.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate bone marrow reserves (neutrophil count >1.5 x10^9 /l and platelet count >100 x10^9/l)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate renal function (serum creatinine \u2264 1.5 x upper limit of normal)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Hepatic function (ALAT, ASAT \u2264 2.5 x upper limit of normal, alkaline phosphatase \u2264 2.5 x upper limit of normal and total bilirubin \u2264 2.0 x upper limit of normal)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Signed informed consent of the patient",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Any patient with confirmed metastatic disease.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with inflammatory breast cancer.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Tumor sample shipped to Agendia with \u2264 30% tumor cells or that fails Quality Assurance or Quality Control criteria.",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients who have had any prior chemotherapy, radiotherapy, or endocrine therapy for the treatment of breast cancer.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Any serious uncontrolled intercurrent infections, or other serious uncontrolled concomitant disease.",
      "label": "unknown",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient is a 42 year-old postmenopausal woman with histologically proven invasive breast cancer and no distant metastases. She has adequate bone marrow reserves, renal function, and hepatic function.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT01501487",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}